A CanBreed researcher takes a sample from a cannabis plant. (photo credit: CANBREED)
The 40-hour course has eight weekly five-hour evening sessions and is intended for entrepreneurs, doctors, investors, researchers, pharmaceutical employees, agricultural experts and academics.
As the future of Israel’s recreational cannabis remains in doubt following the Knesset’s early dispersal, the country’s medical cannabis market continues to grow, leaving it as one of the few industries which have been emboldened during the coronavirus crisis.
Moreover, the pandemic and the various lockdowns which followed it have left many highly qualified Israelis unable to find work in their respective fields.
To help alleviate the crisis, the Technion‘s Continuing Education and External Studies Division – along with Cann10, one of Israel’s leading medical cannabis companies, and AI cannabis analysis start-up GemmaCert – recently announced that they will award two scholarships for the Technion’s external Medical Cannabis Entrepreneurship course for professionals who are interested in joining the medical cannabis industry.
The course teaches students about the various aspects related to the development of products, entrepreneurship, research and investments in the field of medical cannabis, supplying them with an understanding of historical background up to the present day and future challenges and opportunities facing the field.
Each scholarship is for NIS 2,750 – half the tuition fee – which goes toward participation in the eighteenth cycle of the program, which will begin on March 2 at the Technion campus in Sarona, Tel Aviv.
Last year, for the seventeenth cycle of the course, Cann10 partnered with the Technion to supply a full scholarship for women who were interested in entering the field but did not have a formal education on the subject.
The 40-hour course is split up into eight weekly five-hour evening sessions and is intended for entrepreneurs, doctors, investors, researchers, pharmaceutical employees, agricultural experts and academics interested in entering or studying the field.
Published: January 19, 2021
Founder & Interim Editor of L.A. Cannabis News